We are pleased to announce a new partnership between Serum Life Science Europe GmbH (SLS Europe) and INCATE (INCubator for Antibacterial Therapies Europe) in the ongoing battle against antimicrobial resistance…

SLS Europe team, together with Serum Institute of India Pvt. Ltd., presented our leading TB vaccine, VPM1002, contributing to global discussions on TB vaccine innovation. Active engagement and collaboration with…

Collaborating with Serum Institute of India Pvt. Ltd., we are proud partners in advancing the groundbreaking TB vaccine candidate, VPM1002. For deeper insights into our efforts, explore BBC’s coverage on…

With a round of applause and a plethora of insights, Day 2 marks the exciting conclusion of our priMe trial meeting in Entebbe, Uganda.   Highlights of Day Two: Collective…

TUSANYUSE NYO OBALABA (Welcome everyone in Luganda language) The first day at the annual meeting of the pivotal priMe trial held in Entebbe, Uganda, was marked by significant discussions and…

The Phase II/III study, conducted in Germany, assessed the safety and immunogenicity of SIIPL Tdap, a novel booster vaccine for tetanus, diphtheria, and pertussis. This publication represents a significant step…

Renowned vaccine researcher, Prof. Dr. Stefan H. E. Kaufmann, recently shared his expertise and insights on tuberculosis in an exclusive interview with ETHealthworld. Prof. Dr. Kaufmann, the inventor of VPM1002,…